Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation

Nils Erik Magnusson; Mads Hornum; Kaj Anker Jørgensen; Jesper Melchior Hansen; Claus Bistrup; Bo Feldt-Rasmussen; Allan Flyvbjerg

doi:10.1186/1471-2369-13-8

Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation

Nils Erik Magnusson, Mads Hornum, Kaj Anker Jørgensen, Jesper Melchior Hansen, Claus Bistrup, Bo Feldt-Rasmussen, Allan Flyvbjerg

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

33 Citationer (Scopus)

Abstract

Neutrophil gelatinase associated lipocalin (NGAL) is a biomarker of kidney injury. We examined plasma levels of NGAL in a cohort of 57 kidney allograft recipients (Tx group, 39 ± 13 years), a uraemic group of 40 patients remaining on the waiting list (47 ± 11 years) and a control group of 14 healthy subjects matched for age, sex and body mass index (BMI). The kidney graft recipients were studied at baseline before transplantation and 3 and 12 months after transplantation and the uraemic group at baseline and after 12 months.

Originalsprog	Engelsk
Tidsskrift	B M C Nephrology
Vol/bind	13
Sider (fra-til)	8
Antal sider	8
ISSN	1471-2369
DOI	https://doi.org/10.1186/1471-2369-13-8
Status	Udgivet - 2012

Adgang til dokumentet

10.1186/1471-2369-13-8

Citationsformater

Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation. / Magnusson, Nils Erik; Hornum, Mads; Jørgensen, Kaj Anker; Hansen, Jesper Melchior; Bistrup, Claus; Feldt-Rasmussen, Bo; Flyvbjerg, Allan.

I: B M C Nephrology, Bind 13, 2012, s. 8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{7655c1a3f9254b05854b79da0d33fc45,

title = "Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation",

abstract = "Neutrophil gelatinase associated lipocalin (NGAL) is a biomarker of kidney injury. We examined plasma levels of NGAL in a cohort of 57 kidney allograft recipients (Tx group, 39 ± 13 years), a uraemic group of 40 patients remaining on the waiting list (47 ± 11 years) and a control group of 14 healthy subjects matched for age, sex and body mass index (BMI). The kidney graft recipients were studied at baseline before transplantation and 3 and 12 months after transplantation and the uraemic group at baseline and after 12 months.",

author = "Magnusson, {Nils Erik} and Mads Hornum and J{\o}rgensen, {Kaj Anker} and Hansen, {Jesper Melchior} and Claus Bistrup and Bo Feldt-Rasmussen and Allan Flyvbjerg",

year = "2012",

doi = "10.1186/1471-2369-13-8",

language = "English",

volume = "13",

pages = "8",

journal = "BMC Nephrology",

issn = "1471-2369",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation

AU - Magnusson, Nils Erik

AU - Hornum, Mads

AU - Jørgensen, Kaj Anker

AU - Hansen, Jesper Melchior

AU - Bistrup, Claus

AU - Feldt-Rasmussen, Bo

AU - Flyvbjerg, Allan

PY - 2012

Y1 - 2012

N2 - Neutrophil gelatinase associated lipocalin (NGAL) is a biomarker of kidney injury. We examined plasma levels of NGAL in a cohort of 57 kidney allograft recipients (Tx group, 39 ± 13 years), a uraemic group of 40 patients remaining on the waiting list (47 ± 11 years) and a control group of 14 healthy subjects matched for age, sex and body mass index (BMI). The kidney graft recipients were studied at baseline before transplantation and 3 and 12 months after transplantation and the uraemic group at baseline and after 12 months.

AB - Neutrophil gelatinase associated lipocalin (NGAL) is a biomarker of kidney injury. We examined plasma levels of NGAL in a cohort of 57 kidney allograft recipients (Tx group, 39 ± 13 years), a uraemic group of 40 patients remaining on the waiting list (47 ± 11 years) and a control group of 14 healthy subjects matched for age, sex and body mass index (BMI). The kidney graft recipients were studied at baseline before transplantation and 3 and 12 months after transplantation and the uraemic group at baseline and after 12 months.

U2 - 10.1186/1471-2369-13-8

DO - 10.1186/1471-2369-13-8

M3 - Journal article

C2 - 22325322

VL - 13

SP - 8

JO - BMC Nephrology

JF - BMC Nephrology

SN - 1471-2369

ER -